Long-term outcome of the survivors of infantile hypercalcaemia with <i>CYP24A1</i> and <i>SLC34A1</i> mutationsAgnieszka Janiec, Mieczysław Litwin, Aldona Wierzbicka et al.|Nephrology Dialysis Transplantation|2020Cited by 28
Molecular Review of Suspected Alport Syndrome Patients—A Single-Centre ExperiencePaulina Halat, Krystyńa Chrzańowska, Elżbieta Ciara et al.|Genes|2025Cited by 9
Analysis of vitamin D3 metabolites in survivors of infantile idiopathic hypercalcemia caused by CYP24A1 mutation or SLC34A1 mutationEwa Kowalska, Mieczysław Litwin, Ewa Pronicka et al.|The Journal of Steroid Biochemistry and Molecular Biology|2021Cited by 3